Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- HC Wainwright & Co.
- Maxim Group
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Kazia Therapeutics
What is the target price for Kazia Therapeutics (KZIA)?
The latest price target for Kazia Therapeutics (NASDAQ: KZIA) was reported by HC Wainwright & Co. on April 11, 2023. The analyst firm set a price target for $2.00 expecting KZIA to rise to within 12 months (a possible 75.44% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kazia Therapeutics (KZIA)?
The latest analyst rating for Kazia Therapeutics (NASDAQ: KZIA) was provided by HC Wainwright & Co., and Kazia Therapeutics upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Kazia Therapeutics (KZIA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kazia Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kazia Therapeutics was filed on April 11, 2023 so you should expect the next rating to be made available sometime around April 11, 2024.
Is the Analyst Rating Kazia Therapeutics (KZIA) correct?
While ratings are subjective and will change, the latest Kazia Therapeutics (KZIA) rating was a upgraded with a price target of $0.00 to $2.00. The current price Kazia Therapeutics (KZIA) is trading at is $1.14, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.